Semaglutide + B12
Product Description
Semaglutide with Vitamin B12 is a compounded injectable medication used for weight loss and type 2 diabetes management. It combines the GLP-1 agonist semaglutide to lower blood sugar and reduce appetite, with cyanocobalamin (Vitamin B12), which helps increase energy and lessen nausea.

Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for the treatment of type 2 diabetes and obesity. It is marketed under the brand names Mounjaro® (for diabetes) and Zepbound® (for weight management).
Tirzepatide works by activating both GIP and GLP-1 receptors, which are incretin hormones that play important roles in glucose metabolism. This dual action helps:
- Increase insulin secretion when blood glucose levels are elevated
- Decrease glucagon secretion
- Slow gastric emptying
- Reduce appetite and food intake
- Type 2 diabetes mellitus management
- Chronic weight management in adults with obesity or overweight with weight-related comorbidities
- Administered as a once-weekly subcutaneous injection
- Available in multiple dose strengths (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg)
- Dose is typically titrated gradually to improve tolerability
- Nausea, vomiting, diarrhea
- Decreased appetite
- Constipation
- Abdominal pain

